Glenmark Pharmaceuticals gets EIR with VAI status for USA manufacturing facility

27 Nov 2025 Evaluate

Glenmark Pharmaceuticals has received Establishment Inspection Report (EIR) with a Voluntary Action Indicated (VAI) status from the United States Food & Drug Administration (USFDA) for its formulations manufacturing facility situated in Monroe, North Carolina, USA. This is following an inspection conducted by the Agency from June 09 to June 17 2025. The commercial manufacturing at the Monroe site will now restart.

Glenmark Pharmaceuticals is a global research-led pharmaceutical company with presence across Generics, Specialty and OTC business with operations in over 50 countries.

Glenmark Pharma Share Price

1967.15 -7.00 (-0.35%)
05-Dec-2025 14:50 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1802.00
Dr. Reddys Lab 1275.00
Cipla 1518.00
Zydus Lifesciences 930.30
Lupin 2090.15
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×